Impact of Caspase-8 (CASP8) -652 6N Del and D302H Polymorphisms on Prostate Cancer in Different Ethnic Groups |
Zhang, Cheng-Dong
(Medical Scientific Research Center, Guangxi Medical University)
Li, Hong-Tao (Medical Scientific Research Center, Guangxi Medical University) Liu, Kun (Department of Gastroenterology, The Third Hospital of Nanchang City) Lin, Zhi-Di (Department of Urology, Affiliated Hospital of Youjiang Medical College for Nationalities) Peng, Qi-Liu (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) Qin, Xue (Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University) He, Min (Medical Scientific Research Center, Guangxi Medical University) Wu, Hua (Medical Scientific Research Center, Guangxi Medical University) Mo, Zeng-Nan (Department of Urology, First Affiliated Hospital of Guangxi Medical University) Yang, Xiao-Li (Medical Scientific Research Center, Guangxi Medical University) |
1 | Kesarwani P, Mandal RK, Maheshwari R, et al (2011). Influence of caspases 8 and 9 gene promoter polymorphism on prostate cancer susceptibility and early development of hormone refractory prostate cancer. BJU Int, 107, 471-6. DOI ScienceOn |
2 | Klein LT, Lowe FC (1997). The effects of prostatic manipulation on prostate-specific antigen levels. Urol Clin North Am, 24, 293-7. DOI ScienceOn |
3 | Li YY, Wang XM, Lu XZ (2014). KCNQ1 rs2237892 C-->T gene polymorphism and type 2 diabetes mellitus in the Asian population: a meta-analysis of 15,736 patients. J Cell Mol Med, 18, 274-82. DOI |
4 | Lubahn J, Berndt SI, Jin CH, et al (2010). Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. Prostate, 70, 646-53. |
5 | MacPherson G, Healey CS, Teare MD, et al (2004). Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst, 96, 1866-9. DOI ScienceOn |
6 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
7 | Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. DOI ScienceOn |
8 | Meyer A, Coinac I, Bogdanova N, et al (2013). Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy. Urol Oncol, 31, 74-81. DOI ScienceOn |
9 | Michailidou K, Hall P, Gonzalez-Neira A, et al (2013). Largescale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet, 45, 353-61. DOI ScienceOn |
10 | Sergentanis TN, Economopoulos KP (2010). Association of two CASP8 polymorphisms with breast cancer risk: a metaanalysis. Breast Cancer Res Treat, 120, 229-34. DOI |
11 | Son JW, Kang HK, Chae MH, et al (2006). Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet, 169, 121-7. DOI ScienceOn |
12 | Sun T, Gao Y, Tan W, et al (2007). A six-nucleotide insertiondeletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet, 39, 605-13. DOI ScienceOn |
13 | Turnbull C, Ahmed S, Morrison J, et al (2010). Genomewide association study identifies five new breast cancer susceptibility loci. Nat Genet, 42, 504-7. DOI ScienceOn |
14 | Wu Z, Li Y, Li S, et al (2013). Association between main Caspase gene polymorphisms and the susceptibility and prognosis of colorectal cancer. Med Oncol, 30, 565. DOI ScienceOn |
15 | Zhao CX, Liu M, Wang JY, et al (2013). Association of 8 loci on chromosome 8q24 with prostate carcinoma risk in northern Chinese men. Asian Pac J Cancer Prev, 14, 6733-8. 과학기술학회마을 DOI ScienceOn |
16 | Zheng SL, Sun J, Wiklund F, et al (2008). Cumulative association of five genetic variants with prostate cancer. N Engl J Med, 358, 910-9. DOI ScienceOn |
17 | Zhou X, Gu Y, Zhang SL (2012). Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis. Asian Pac J Cancer Prev, 13, 4909-14. 과학기술학회마을 DOI ScienceOn |
18 | Cybulski. C, Wokolorczyk. D, Gliniewicz. B (2007). A sixnucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population. Breast Cancer Res Treat, 112, 367-368. |
19 | Benjamini Y, Hochberg Y (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Royal Statistical Society, 57, 11. |
20 | Bethke L, Sullivan K, Webb E, et al (2009). CASP8 D302H and meningioma risk: an analysis of five case-control series. Cancer Lett, 273, 312-5. DOI ScienceOn |
21 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. DOI ScienceOn |
22 | Frank B, Rigas SH, Bermejo JL, et al (2008). The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res Treat, 111, 139-44. DOI ScienceOn |
23 | Fu G, Tang J, Wang M, et al (2011). CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men. J Biomed Res, 25, 128-34. DOI ScienceOn |
24 | George GP, Mandal RK, Kesarwani P, et al (2010). Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: a case-control study in cohort of North India. Urol Oncol, 30, 781-9. |
25 | Ho PK, Hawkins CJ (2005). Mammalian initiator apoptotic caspases. FEBS J, 272, 5436-53. DOI ScienceOn |
26 | Haiman CA, Garcia RR, Kolonel LN, et al (2008). A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nat Genet, 40, 259-60. DOI ScienceOn |
27 | Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. DOI ScienceOn |
28 | Hirschhorn JN, Lohmueller K, Byrne E, et al (2002). A comprehensive review of genetic association studies. Genet Med, 4, 45-61. DOI ScienceOn |
29 | Holm S (1979). A simple sequentially rejective multiple test procedure. Scandinavian J Statistics, 6, 65-70. |